Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation
Cardioembolic complications such as ischemic stroke and non-central nervous system venous thrombosis are among the most serious consequences of atrial fibrillation (AF) [1, 2]. The most effective way to prevent the complications is a long-term (indefinitely long) administration of anticoagulants, wh...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2014-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/684 |
| Summary: | Cardioembolic complications such as ischemic stroke and non-central nervous system venous thrombosis are among the most serious consequences of atrial fibrillation (AF) [1, 2]. The most effective way to prevent the complications is a long-term (indefinitely long) administration of anticoagulants, which, according to modern beliefs, are indicated in patients with atrial fibrillation with additional risk factors for cardiovascular complications. |
|---|---|
| ISSN: | 2079-701X 2658-5790 |